Charles P. Lattuada Jr., MD
NPI 1407858244ActiveIndividual· Internal Medicine, Medical Oncology· Anniston, AL
Internal Medicine, Medical Oncology (MD) in Anniston, Alabama, trained at Uniformed Services Uhs Fe Hebert School of Med (class of 1983). Part D covered 167 prescriptions written in 2024, 86% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 11 companies reporting payments in 2025, $2,504 in all, mostly consulting fees.
Overview
| NPI | 1407858244 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Aug 11, 2005 |
| Last updated in NPPES | Aug 29, 2019 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Medical Oncology Primary | 207RX0202X | 18922 | AL |
| Internal Medicine, Infectious Disease | 207RI0200X | 18922 | AL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (AL); Practitioner - Internal Medicine (WI) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 167 · 218 30-day fills |
|---|---|
| Patients | 73 |
| Total drug cost | $258,116 |
| Generic share | 86% of claims |
Education and affiliations
| Medical school | Uniformed Services Uhs Fe Hebert School of Med |
|---|---|
| Graduation year | 1983 |
| Medicare specialty | Medical Oncology |
| Secondary specialties | Infectious Disease |
Medical group
- Alabama Cancer Care, LLCMontgomery, AL · 20 clinicians
Hospital affiliations
- Dekalb Regional Medical CenterFort Payne, AL
- The East Alabama Healthcare AuthorityOpelika, AL
Industry payments (Open Payments)
- 2025$2,504 · 25 payments from 11 companies
- 2024$901.91 · 40 payments from 23 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,193 | 9 |
| Novartis Pharmaceuticals Corporation | $61.69 | 3 |
| Eisai Inc. | $55.87 | 3 |
| Recordati_rare_diseases_inc. | $43.50 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.11 | 2 |
What the 2025 payments were for
- Consulting Fee$1,675 · 2 payments
- Food and Beverage$559.80 · 22 payments
- Travel and Lodging$269.36 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records